CMS SUPATRAK LIMITED
Company number 02836006 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Score: F (Critical Condition)
This grade reflects the fact that the patient is, in corporate terms, in the intensive care unit. Despite showing some encouraging vital signs in its latest filed accounts, the company is currently in Administration. An "F" grade indicates severe financial distress, insolvency, and the cessation of normal independent operations.
1. Key Vital Signs
Pulse (Cash Position): Strengthening, but deceptive Cash at bank increased significantly from £42,245 in 2022 to £282,063 in 2023. On the surface, this looks like a healthy pulse, but in the context of Administration, it is often the result of holding creditor funds rather than operational profitability.
Blood Pressure (Liquidity & Working Capital): Dangerously low Net current assets dropped from £462,580 to £292,166. While still technically positive, the "blood pressure" of the business is insufficient to pump enough oxygen to the extremities. Current liabilities (£1.38m) are being serviced, but the overall structural debt creates immense pressure on the system.
Cholesterol (Liabilities & Accumulated Losses): Severely blocked arteries Total liabilities heavily outweigh total assets. The Profit and Loss reserve shows a massive accumulated loss of £1.58 million. This represents years of financial "plaque" building up, restricting the company's financial flexibility and eating away at its equity base.
Temperature (Profitability): Cooling, but still running a fever The operating loss reduced from £407,081 in 2022 to £157,423 in 2023, and the net loss for the year improved from £369,018 to £129,028. The fever is breaking slightly, but the patient is still losing blood (money) on an operating basis.
2. Diagnosis
Primary Condition: Insolvency and Administration The most critical symptom is the company's official status: "In Administration". This means the company has suffered a corporate cardiac arrest and external administrators have been appointed to take over the "life support"—managing the company's affairs to repay creditors.
Secondary Condition: Severe Negative Equity (Net Assets Deficit) The financial data reveals a company with negative net assets of £1,485,211 and negative shareholders' funds of £1,585,748. In medical terms, the business is severely malnourished; its debts far exceed its assets, meaning it is technically insolvent on a balance sheet basis.
Contradictory Symptoms: The "Going Concern" Delusion There is a startling contradiction in the filed accounts. The directors' report, signed in September 2024, states that the directors have a "reasonable expectation that the company has adequate resources to continue in operational existence" and adopted the "going concern basis." However, the company is currently in Administration. This is akin to a patient declaring themselves fit to run a marathon while the surgeon is actively performing open-heart surgery. This prior-year optimism has been superseded by the harsh reality of the current Administration status.
Underlying Pathology: Chronic Loss-Making While turnover grew healthily from £4.66m to £4.91m, the cost of sales and administrative expenses consistently outpace revenue, leading to operating losses. The business model appears to be suffering from a chronic inability to convert sales into profit.
3. Recommendations
Because the patient is already in Administration, the usual prescriptions (cost-cutting, restructuring debt) are now in the hands of the appointed administrators. However, for stakeholders and directors, the following steps are critical:
-
For the Directors: Cooperate with the "Surgeons" The directors must step back and cooperate fully with the administrators. Any attempt to manage the company's finances independently is not only futile but potentially legally hazardous. Full transparency of financial records is required.
-
Explore a "Transplant" (Pre-Pack Sale) If the underlying operational tissue (the telematics business, subscriber base, and technology) is healthy, the administrators may seek to sell the viable parts of the business to a new owner. This is a corporate transplant—saving the good tissue while discarding the insolvent shell. Stakeholders should prepare for this possibility.
-
For Creditors: Triage Your Expectations Unsecured creditors should expect significant losses. With negative net assets and administrators' costs to be paid first, the queue for repayment is long and the funds are minimal. Creditors should formally register their claims and prepare for a minimal return.
-
Review the Prior Year Adjustment The 2022 accounts were restated due to a £132,891 impairment provision for redundant stock. This suggests previous financial reporting may have been overly optimistic, masking the true extent of the illness. Future operators of the business must ensure highly conservative inventory valuation to prevent a relapse.